Literature DB >> 4986625

[Oral antimycotic agent, 5-fluorocytosine].

H J Scholer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4986625     DOI： 10.1111/j.1439-0507.1970.tb01248.x

Source DB:  PubMed          Journal:  Mykosen        ISSN： 0027-5557


× No keyword cloud information.
  5 in total

1.  Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis.

Authors:  D T A te Dorsthorst; P E Verweij; J F G M Meis; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Candidiasis of the urinary tract.

Authors:  J T Hill
Journal:  Proc R Soc Med       Date:  1974-11

3.  Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine.

Authors:  J Schönebeck; E Segerbrand
Journal:  Br Med J       Date:  1973-11-10

4.  Experimental and clinical studies of 5-fluorocytosine activity in candida ocular infections, II. The effect of 5-fluorocytosine in treating experimental candida infection in rabbits' eyes.

Authors:  E Segal; A Romano; E Eylan; R Stein
Journal:  Infection       Date:  1975       Impact factor: 3.553

5.  In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.

Authors:  S Normark; J Schönebeck
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.